Biotech Blueprint

• CDC’s Autism Reversal Shocks Experts, mRNA Flu Shot Advances, Big Oncology Wins - This Week in Biotech #79

  Subscribe to Biotech Blueprint at biotechblueprint.com

  --------  

  6:05

  --------

  6:05
• FDA Opens New Pathway, Pfizer’s $10B GLP-1 Win, and Biotech’s Return to Offense — This Week in Biotech #78

  Subscribe to Biotech Blueprint for free at biotechblueprint.com. A week of rare regulatory momentum, strategic M&A, and meaningful clinical wins.

  --------  

  7:32

  --------

  7:32
• Inside Sensible Biotechnologies: Reinventing mRNA Manufacturing

  Subscribe to Biotech Blueprint at biotechblueprint.com In today's episode:How an Oxford-born, YC-backed startup is betting that cell-based production will define mRNA’s next decade.

  --------  

  51:45

  --------

  51:45
• Trump Reshapes Obesity Drug Prices, Novo Tops Pfizer Again — This Week in Biotech #77

  Subscribe to Biotech Blueprint for free at biotechblueprint.com.Pfizer’s courtroom gamble to block Novo Nordisk’s $10B Metsera takeover failed, and Novo immediately fired back with an even higher bid, leaving Pfizer two days to respond before the Nov. 13 vote. Meanwhile, Trump struck landmark pricing deals with Novo and Lilly to bring GLP-1 drugs like Ozempic and Mounjaro to Medicare at $245 a month. Moderna tightened its belt and beat expectations with $1 B in revenue, J&J scored an FDA win for Caplyta in depression, and Viking’s next-gen GLP-1 showed it can actually reverse metabolic syndrome.

  --------  

  6:58

  --------

  6:58
• Novo tops Pfizer’s obesity bid; FDA moves to speed biosimilar approvals; Moderna–Merck rumors build — This Week in Biotech #76

  Subscribe to Biotech Blueprint newsletter for free at biotechblueprint.com.

  --------  

  3:46

  --------

  3:46

Mais podcasts de Tecnologia

Podcasts em tendência em Tecnologia

Sobre Biotech Blueprint